These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2680433)

  • 21. Effect of intravenous propranolol on portal hypertension.
    Gupta KM; Chadda S; Chadda VS; Panwar RB; Sharda DP; Mishra SN; Chaudhary A
    J Assoc Physicians India; 1984 Apr; 32(4):343-4. PubMed ID: 6746547
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of Half-Inderal LA and Inderal LA in the treatment of hypertension in elderly subjects.
    Datta SR
    Br J Clin Pract; 1989 Mar; 43(3):102-8. PubMed ID: 2692687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
    Schepke M; Wiest R; Flacke S; Heller J; Stoffel-Wagner B; Herold T; Ghauri M; Sauerbruch T
    Am J Gastroenterol; 2008 May; 103(5):1152-8. PubMed ID: 18422814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting propranolol (Inderal LA): pharmacokinetics, pharmacodynamics and therapeutic use.
    Mishriki AA; Weidler DJ
    Pharmacotherapy; 1983; 3(6):334-41. PubMed ID: 6361703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Propranolol in children and adolescents with portal hypertension: its dosage and the clinical, cardiovascular and biochemical effects].
    de Kolster CC; Rapa de Higuera M; Carvajal A; Castro J; Callegari C; Kolster J
    G E N; 1992; 46(3):199-207. PubMed ID: 1340825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-blockers in portal hypertension: Unexpected limitations!].
    Thevenot T; Cervoni JP; Di Martino V
    Presse Med; 2011 Mar; 40(3):227-9. PubMed ID: 21093210
    [No Abstract]   [Full Text] [Related]  

  • 28. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II].
    Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S
    Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of once daily long acting propranolol hydrochloride (Inderal LA and Half-Inderal LA) in the treatment of anxiety. A double-blind placebo-controlled general practice study.
    Hudson CF
    Br J Clin Pract; 1988 Oct; 42(10):419-26. PubMed ID: 3076469
    [No Abstract]   [Full Text] [Related]  

  • 32. Propranolol and portal hypertension in cirrhosis.
    Wilkinson RP
    Lancet; 1980 Aug; 2(8191):429. PubMed ID: 6105550
    [No Abstract]   [Full Text] [Related]  

  • 33. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 37. Portal hypertension therapy with oral propranolol. A short-term study.
    Choudhary A; Dogra J; Chadda VS; Sulemani AA; Misra SN
    J Assoc Physicians India; 1990 Mar; 38(3):213-4. PubMed ID: 2202706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol in decompensated alcoholic cirrhosis.
    Colman JC; Jennings GL; McLean AJ; Mignot PR; Dudley FJ
    Lancet; 1982 Nov; 2(8306):1040-1. PubMed ID: 6127517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.